Designer T cells by T cell receptor replacement

被引:83
|
作者
Sommermeyer, Daniel
Neudorfer, Julia
Weinhold, Monika
Leisegang, Matthias
Engels, Boris
Noessner, Elfriede
Heemskerk, Mirjam H. M.
Charo, Jehad
Schendel, Dolores J.
Blankenstein, Thomas
Bernhard, Helga
Uckert, Wolfgang
机构
[1] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Hematol Oncol, D-8000 Munich, Germany
[3] Inst Immunol, Berlin, Germany
[4] Humboldt Univ, Inst Biol, D-1086 Berlin, Germany
[5] GSF Natl Res Ctr Environm & Hlth, Inst Mol Immunol, Munich, Germany
[6] Leiden Univ, Ctr Med, Dept Hematol, Lab Expt Hematol, NL-2300 RA Leiden, Netherlands
[7] GSF Natl Res Ctr Environm & Hlth, Clin Cooperat Grp Antigen Specif Immunotherapy, Munich, Germany
[8] Tech Univ Munich, D-8000 Munich, Germany
关键词
gene therapy; T cells; TCR; TCR replacement;
D O I
10.1002/eji.200636539
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell receptor (TCR) gene transfer is a convenient method to produce antigen-specific T cells for adoptive therapy. However, the expression of two TCR in T cells could impair their function or cause unwanted effects by mixed TCR heterodimers. With five different TCR and four different T cells, either mouse or human, we show that some TCR are strong - in terms of cell surface expression - and replace weak TCR on the cell surface, resulting in exchange of antigen specificity. Two strong TCR are co-expressed. A mouse TCR replaces human TCR on human T cells. Even though it is still poorly understood why some TCR alpha/beta combinations are preferentially expressed on T cells, our data suggest that, in the future, designer T cells with exclusive tumor reactivity can be generated by T cell engineering.
引用
收藏
页码:3052 / 3059
页数:8
相关论文
共 50 条
  • [1] ORTHOTOPIC T CELL RECEPTOR REPLACEMENT NEXT - GENERATION ENGINEERING OF T CELLS FOR THERAPY
    Schober, K.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A28 - A28
  • [2] Designer T-cells and T-cell receptors for customized cancer immunotherapies
    Legut, Mateusz
    Sewell, Andrew K.
    CURRENT OPINION IN PHARMACOLOGY, 2018, 41 : 96 - 103
  • [3] Designer T Cells: Can T Cells with Defined Specificity Make Adoptive Cell Therapy Successful?
    Abken, H.
    TRANSFUSIONSMEDIZIN, 2014, 4 (04) : 179 - 183
  • [4] MHC-restricted T cell receptor signaling is required for αβ TCR replacement of the pre T cell receptor
    Croxford, Andrew L.
    Akilli-Ozturk, Oezlem
    Rieux-Laucat, Frederic
    Foerster, Irmgard
    Waisman, Ari
    Buch, Thorsten
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (02) : 391 - 399
  • [5] The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
    Legut, Mateusz
    Cole, David K.
    Sewell, Andrew K.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2015, 12 (06) : 656 - 668
  • [6] The T-cell receptor repertoire of regulatory T cells
    Pacholczyk, Rafal
    Kern, Joanna
    IMMUNOLOGY, 2008, 125 (04) : 450 - 458
  • [7] The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
    Mateusz Legut
    David K Cole
    Andrew K Sewell
    Cellular & Molecular Immunology, 2015, 12 : 656 - 668
  • [8] Designer T cells in prostate cancer
    Day-Webb, Robert
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (09) : 1528 - 1528
  • [9] T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
    Fanlin Li
    Huihui Zhang
    Wanting Wang
    Puyuan Yang
    Yue Huang
    Junshi Zhang
    Yaping Yan
    Yuan Wang
    Xizhong Ding
    Jie Liang
    Xinyue Qi
    Min Li
    Ping Han
    Xiaoqing Zhang
    Xin Wang
    Jiang Cao
    Yang-Xin Fu
    Xuanming Yang
    Nature Communications, 13
  • [10] T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
    Li, Fanlin
    Zhang, Huihui
    Wang, Wanting
    Yang, Puyuan
    Huang, Yue
    Zhang, Junshi
    Yan, Yaping
    Wang, Yuan
    Ding, Xizhong
    Liang, Jie
    Qi, Xinyue
    Li, Min
    Han, Ping
    Zhang, Xiaoqing
    Wang, Xin
    Cao, Jiang
    Fu, Yang-Xin
    Yang, Xuanming
    NATURE COMMUNICATIONS, 2022, 13 (01)